Last updated on December 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hosp Sant J. Despi-Moises Brog /ID# 128347
Barcelona, Spain
0.88miles
  Connect »

ABBVIE CALL CENTER

Hospital Duran i Reynals /ID# 98584
L'Hospitalet de Llobregat, Spain
1.34miles
  Connect »

ABBVIE CALL CENTER

Hospital Sant Joan de Deu /ID# 155774
Esplugues de Llobregat, Spain
1.53miles
  Connect »

ABBVIE CALL CENTER

Hospital viladecans /ID# 155500
Barcelona, Spain
3.23miles
  Connect »

ABBVIE CALL CENTER

Hospital Parc de Salut del Mar /ID# 126637
Barcelona, Spain
3.79miles
  Connect »

ABBVIE CALL CENTER

Hospital Univ Germans Trias I /ID# 98592
Barcelona, Spain
9.49miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.